Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
Philips’ system combines features from other existing products to enable users to perform nearby fluoroscopy and digital x-rays using a single device.
In a settlement with the SEC, Holmes gave up control of Theranos and paid a $500,000 penalty.
Abiomed has agreed to pay $3.1 million to settle allegations it took physicians for expensive, boozy dinners to encourage them to use its heart pumps.
The FDA has received a glut of safety reports related to Bayer’s birth control device Essure.
The 510(k) nod clears Panther to sell a device designed to deliver continuous compression during bone healing while allowing joint motion.
Approval of the Oxford Immunotec tests give the U.S. a way to stop the spread of babesiosis, a life-threatening disease carried by deer ticks.
The FDA approved Abbott’s Masters HP 15mm device that will allow surgeons to treat infants and children who need mitral or aortic valve replacement.
Corindus sees the software update expanding use of percutaneous coronary intervention technology CorPath GRX to more complex procedures.
The European regulatory nod clears Reva to push a device it thinks addresses some shortcomings of other products in the sector.
The new guidelines suggest TST and IGRA as options for latent TB testing, regardless of the wealth or disease prevalence of the country.